GlassScriptPhysician profile
Debra Emery
NPI 1164634168
$2,822.15
in general payments reported to CMS, 2019-2025
15 companies · $534 in 2025
The $534 reported for 2025 was more than what 76% of Child & Adolescent Psychiatry providers received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $45.56 · 2021: $309 · 2022: $484 · 2023: $297 · 2024: $534 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $461.78 | 2019-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Alkermes, INC. | $434.79 | 2019-2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $420.19 | 2019-2025 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $388.43 | 2019-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $363.51 | 2021-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Corium, LLC | $187.72 | 2022-2025 | Azstarys |
| Vanda Pharmaceuticals INC. | $142.98 | 2019-2025 | Fanapt, Hetlioz |
| E.R. Squibb & Sons, L.L.C. | $121.19 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $88.15 | 2024-2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $58.01 | 2019 | |
| Lundbeck LLC | $53.72 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.08 | 2021 | |
| Abbvie INC. | $28.44 | 2025 | |
| Bausch Health US, LLC | $22.16 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Emery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.